169 related articles for article (PubMed ID: 27880939)
41. Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney.
Roy A; Kumar V; Zorman B; Fang E; Haines KM; Doddapaneni H; Hampton OA; White S; Bavle AA; Patel NR; Eldin KW; John Hicks M; Rakheja D; Leavey PJ; Skapek SX; Amatruda JF; Nuchtern JG; Chintagumpala MM; Wheeler DA; Plon SE; Sumazin P; Parsons DW
Nat Commun; 2015 Nov; 6():8891. PubMed ID: 26573325
[TBL] [Abstract][Full Text] [Related]
42. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor.
Srinivasan RS; de Erkenez AC; Hemenway CS
Oncogene; 2003 May; 22(22):3395-406. PubMed ID: 12776190
[TBL] [Abstract][Full Text] [Related]
43. A Pan-Cancer Landscape Analysis Reveals a Subset of Endometrial Stromal and Pediatric Tumors Defined by Internal Tandem Duplications of BCOR.
Juckett LT; Lin DI; Madison R; Ross JS; Schrock AB; Ali S
Oncology; 2019; 96(2):101-109. PubMed ID: 30380541
[TBL] [Abstract][Full Text] [Related]
44. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
[TBL] [Abstract][Full Text] [Related]
45. BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets.
Nakata S; Yuan M; Rubens JA; Kahlert UD; Maciaczyk J; Raabe EH; Eberhart CG
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920124
[TBL] [Abstract][Full Text] [Related]
46. Control of endothelial sprouting by a Tel-CtBP complex.
Roukens MG; Alloul-Ramdhani M; Baan B; Kobayashi K; Peterson-Maduro J; van Dam H; Schulte-Merker S; Baker DA
Nat Cell Biol; 2010 Oct; 12(10):933-42. PubMed ID: 20835243
[TBL] [Abstract][Full Text] [Related]
47. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
[TBL] [Abstract][Full Text] [Related]
48. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
49. HIF-2α Expression Regulates Sprout Formation into 3D Fibrin Matrices in Prolonged Hypoxia in Human Microvascular Endothelial Cells.
Nauta TD; Duyndam MC; Weijers EM; van Hinsbergh VM; Koolwijk P
PLoS One; 2016; 11(8):e0160700. PubMed ID: 27490118
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of proliferation, sprouting, tube formation and Tie2 signaling of lymphatic endothelial cells by the histone deacetylase inhibitor SAHA.
Cheng HT; Hung WC
Oncol Rep; 2013 Aug; 30(2):961-7. PubMed ID: 23754070
[TBL] [Abstract][Full Text] [Related]
51. Serum induces transcription of Hey1 and Hey2 genes by Alk1 but not Notch signaling in endothelial cells.
Wöltje K; Jabs M; Fischer A
PLoS One; 2015; 10(3):e0120547. PubMed ID: 25799559
[TBL] [Abstract][Full Text] [Related]
52. Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression.
Noseda M; Chang L; McLean G; Grim JE; Clurman BE; Smith LL; Karsan A
Mol Cell Biol; 2004 Oct; 24(20):8813-22. PubMed ID: 15456857
[TBL] [Abstract][Full Text] [Related]
53. Rac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promoters.
Barros P; Lam EW; Jordan P; Matos P
Nucleic Acids Res; 2012 Sep; 40(16):7776-87. PubMed ID: 22723377
[TBL] [Abstract][Full Text] [Related]
54. Endothelial cell-derived interleukin-6 regulates tumor growth.
Neiva KG; Warner KA; Campos MS; Zhang Z; Moren J; Danciu TE; Nör JE
BMC Cancer; 2014 Feb; 14():99. PubMed ID: 24533454
[TBL] [Abstract][Full Text] [Related]
55. BCOR regulates mesenchymal stem cell function by epigenetic mechanisms.
Fan Z; Yamaza T; Lee JS; Yu J; Wang S; Fan G; Shi S; Wang CY
Nat Cell Biol; 2009 Aug; 11(8):1002-9. PubMed ID: 19578371
[TBL] [Abstract][Full Text] [Related]
56. Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein-Protein Interaction Interface.
Sameshima T; Yamamoto T; Sano O; Sogabe S; Igaki S; Sakamoto K; Ida K; Gotou M; Imaeda Y; Sakamoto J; Miyahisa I
Biochemistry; 2018 Feb; 57(8):1369-1379. PubMed ID: 29293322
[TBL] [Abstract][Full Text] [Related]
57. Atypical E2Fs inhibit tumor angiogenesis.
Weijts BGMW; Westendorp B; Hien BT; Martínez-López LM; Zijp M; Thurlings I; Thomas RE; Schulte-Merker S; Bakker WJ; de Bruin A
Oncogene; 2018 Jan; 37(2):271-276. PubMed ID: 28925392
[TBL] [Abstract][Full Text] [Related]
58. BCOR involvement in cancer.
Astolfi A; Fiore M; Melchionda F; Indio V; Bertuccio SN; Pession A
Epigenomics; 2019 May; 11(7):835-855. PubMed ID: 31150281
[No Abstract] [Full Text] [Related]
59. Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6.
Kerres N; Steurer S; Schlager S; Bader G; Berger H; Caligiuri M; Dank C; Engen JR; Ettmayer P; Fischerauer B; Flotzinger G; Gerlach D; Gerstberger T; Gmaschitz T; Greb P; Han B; Heyes E; Iacob RE; Kessler D; Kölle H; Lamarre L; Lancia DR; Lucas S; Mayer M; Mayr K; Mischerikow N; Mück K; Peinsipp C; Petermann O; Reiser U; Rudolph D; Rumpel K; Salomon C; Scharn D; Schnitzer R; Schrenk A; Schweifer N; Thompson D; Traxler E; Varecka R; Voss T; Weiss-Puxbaum A; Winkler S; Zheng X; Zoephel A; Kraut N; McConnell D; Pearson M; Koegl M
Cell Rep; 2017 Sep; 20(12):2860-2875. PubMed ID: 28930682
[TBL] [Abstract][Full Text] [Related]
60. Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer.
Flister MJ; Tsaih SW; Stoddard A; Plasterer C; Jagtap J; Parchur AK; Sharma G; Prisco AR; Lemke A; Murphy D; Al-Gizawiy M; Straza M; Ran S; Geurts AM; Dwinell MR; Greene AS; Bergom C; LaViolette PS; Joshi A
Breast Cancer Res Treat; 2017 Aug; 165(1):53-64. PubMed ID: 28567545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
